Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
Idiopathic Pulmonary Fibrosis (IPF) is a chronic and progressive lung disease that requires effective therapeutic interventions. The development of targeted treatments has brought new hope to patients, and a key chemical intermediate enabling these advancements is Methyl 2-oxoindole-6-carboxylate (CAS 14192-26-8).
Methyl 2-oxoindole-6-carboxylate is critically important as a precursor in the synthesis of Nintedanib Esylate. Nintedanib is a well-established triple angiokinase inhibitor that not only targets cancer pathways but also addresses the fibrotic processes involved in IPF. Its approval for treating this debilitating lung condition underscores the significance of its chemical building blocks.
For pharmaceutical companies and research institutions involved in developing IPF therapies, securing a consistent and high-quality supply of Methyl 2-oxoindole-6-carboxylate is essential. Buyers looking to purchase this intermediate are advised to seek out reputable manufacturers and suppliers, particularly those based in China, where a strong chemical manufacturing infrastructure exists. When inquiring about this product, focus on obtaining detailed specifications, especially purity levels, and requesting a quote for your required quantities.
The availability of high-purity Methyl 2-oxoindole-6-carboxylate from reliable suppliers enables researchers to conduct vital studies and manufacturers to scale up production efficiently. The ability to buy this intermediate with confidence, knowing it meets stringent quality standards, supports the continuous advancement of IPF treatment options. Engaging with suppliers who can offer both R&D quantities and commercial volumes ensures a seamless transition from laboratory research to market-ready pharmaceuticals.
In essence, Methyl 2-oxoindole-6-carboxylate is more than just a chemical compound; it's a vital enabler of advanced medical treatments. By partnering with dependable manufacturers, the pharmaceutical industry can ensure the continued progress in combating diseases like IPF.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
